Sign in
Explore the registryTrack Donanemab's trials

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DonanemabOngoingActive not recruitingPhase 3Open NCT05508789 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT05508789 · Trial Tracker · ComplyRx